Aché
Manufacturing · Brazil · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Harbor Church 2 Rodovia Presidente Dutra...Phone Number
+55 1126086000Website
www.ache.com.brRevenue
$626.5 MillionIndustry
About Aché
Aché Org Chart
Is Aché your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Aché recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Aché, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Aché is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Aché had a recent Job posting/layoffs
Product Launch: Get notified when Aché launches new products
Check if Aché has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Aché has new funding data
Congratulate Masked Content for being promoted to Masked Content at Aché
Recommended Actions
Find VP level buyers at Aché
Find more new buyers
Company Profile Activity
Activity Insights
Aché is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aché is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aché.
Aché Tech Stack
A closer look at the technologies used by Aché
Most Recent Scoops
Aché News & Media
Celmatix and Aché Laboratórios Announce Collaboration to Investigate a Novel Melatonin Receptor Agonists for Women’s Health
NEW YORK--(BUSINESS WIRE)--Celmatix Inc., a leading women’s health biotech focused on ovarian biology, and Aché Laboratórios, a leading Brazilian pharmaceutical company, today announced a collaboration and license option agreement to jointly investigate a novel peripherally preferred melatonin receptor agonist, discovered by Aché, for Women's Health indications. Today’s news follows Celmatix’s April announcement of the second of its three internal drug programs, targeting melatonin receptors ouMcQuade Center for Strategic Research and Development Enters Collaboration with Aché to Develop Potential Treatment for General Anxiety Disorder and Post-Traumatic Stress Disorder
PRINCETON, N.J.--(BUSINESS WIRE)--The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical companies, announces today that it has entered an agreement with Aché Laboratórios Farmacêuticos S.A. (Aché), a leader in the Latin American pharmaceutical market, to co-develop a therapy with the potential to treat general anxiety disorder (GAD) and post-traumatic stress disorder (PTSD). Under the terms of the agreement, MSRD and Aché w
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Aché
Aché is a pharmaceutical company dedicated to improving people's health and well-being for nearly 60 years. They provide a diverse range of innovative and high-quality products across major therapeutic classes, including prescription medications, dermocosmetics, and dietary supplements. Their primary clients include consumers, pharmacies, and healt... Read More